NANOG and ovarian carcinoma: Even more, the overexpression of NANOG in the epithelial ovarian cancer was associated with a high grade tumor, advanced clinical stage of disease [13–15], resistance to chemotherapy [14], and shorter patient survival rate [14, 15].